Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
$1.23
-8.2%
$1.56
$1.10
$8.44
$3.18M1.72179,712 shs164,987 shs
Arch Therapeutics, Inc. stock logo
ARTH
Arch Therapeutics
$0.12
$0.16
$1.57
$763K4.024,068 shsN/A
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
$5.82
+0.2%
$6.71
$5.11
$3,756.00
$2.78M-0.191.16 million shs8,865 shs
United American Healthcare Corp. stock logo
UAHC
United American Healthcare
$0.02
$0.02
$0.01
$0.11
$1.88M-1.510,032 shs1 shs
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
0.00%+6.03%+0.41%-57.99%-47.53%
Arch Therapeutics, Inc. stock logo
ARTH
Arch Therapeutics
0.00%0.00%0.00%-99.25%-99.87%
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
0.00%-6.58%-0.51%-37.14%-99.56%
United American Healthcare Corp. stock logo
UAHC
United American Healthcare
0.00%+6.62%+11.11%-5.29%-66.46%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
1.2249 of 5 stars
3.02.00.00.00.00.01.3
Arch Therapeutics, Inc. stock logo
ARTH
Arch Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
0.5214 of 5 stars
0.04.00.00.01.90.80.0
United American Healthcare Corp. stock logo
UAHC
United American Healthcare
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
2.00
Hold$56.004,452.85% Upside
Arch Therapeutics, Inc. stock logo
ARTH
Arch Therapeutics
0.00
N/AN/AN/A
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
0.00
N/AN/AN/A
United American Healthcare Corp. stock logo
UAHC
United American Healthcare
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest ARTH, AEMD, UAHC, and GCTK Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/7/2025
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral
(Data available from 8/10/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
$570K5.59N/AN/A$2.55 per share0.48
Arch Therapeutics, Inc. stock logo
ARTH
Arch Therapeutics
$80K0.00N/AN/A($2.43) per share0.00
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
N/AN/AN/AN/A($983.43) per shareN/A
United American Healthcare Corp. stock logo
UAHC
United American Healthcare
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
-$13.39M-$12.64N/AN/AN/AN/A-221.38%-156.83%8/13/2025 (Estimated)
Arch Therapeutics, Inc. stock logo
ARTH
Arch Therapeutics
-$6.98MN/A0.00N/AN/A-8,257.70%N/A-730.22%8/18/2025 (Estimated)
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
-$22.60M-$56.60N/AN/AN/AN/A-544.87%8/12/2025 (Estimated)
United American Healthcare Corp. stock logo
UAHC
United American Healthcare
$240KN/A0.00N/AN/AN/AN/AN/A

Latest ARTH, AEMD, UAHC, and GCTK Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/13/2025Q1 2026
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
-$0.68N/AN/AN/AN/AN/A
5/14/2025Q1 2025
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
N/A-$20.40N/A-$0.67N/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
N/AN/AN/AN/AN/A
Arch Therapeutics, Inc. stock logo
ARTH
Arch Therapeutics
N/AN/AN/AN/AN/A
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
N/AN/AN/AN/AN/A
United American Healthcare Corp. stock logo
UAHC
United American Healthcare
$0.08496.89%N/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
N/A
3.13
3.13
Arch Therapeutics, Inc. stock logo
ARTH
Arch Therapeutics
N/A
0.10
0.01
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
0.03
4.85
4.85
United American Healthcare Corp. stock logo
UAHC
United American Healthcare
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
1.99%
Arch Therapeutics, Inc. stock logo
ARTH
Arch Therapeutics
6.91%
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
10.92%
United American Healthcare Corp. stock logo
UAHC
United American Healthcare
N/A

Insider Ownership

CompanyInsider Ownership
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
1.20%
Arch Therapeutics, Inc. stock logo
ARTH
Arch Therapeutics
4.50%
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
12.91%
United American Healthcare Corp. stock logo
UAHC
United American Healthcare
14.31%
CompanyEmployeesShares OutstandingFree FloatOptionable
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
102.59 million2.55 millionNo Data
Arch Therapeutics, Inc. stock logo
ARTH
Arch Therapeutics
104.74 million4.53 millionNot Optionable
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
5480,000415,000Not Optionable
United American Healthcare Corp. stock logo
UAHC
United American Healthcare
31117.06 million100.31 millionNot Optionable

Recent News About These Companies

United American Healthcare CorpShs
HH Health System, United Healthcare reach agreement
Health Care Is on the Ballot Again

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Aethlon Medical stock logo

Aethlon Medical NASDAQ:AEMD

$1.23 -0.11 (-8.21%)
Closing price 08/8/2025 04:00 PM Eastern
Extended Trading
$1.28 +0.05 (+4.07%)
As of 08/8/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Aethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation. The company was incorporated in 1999 and is based in San Diego, California.

Arch Therapeutics stock logo

Arch Therapeutics OTCMKTS:ARTH

Arch Therapeutics, Inc., together with its subsidiaries, operates as a biotechnology company in the United States. It develops and markets products based on its AC5 self-assembling technology platform to stop bleeding and control leaking, as well as manages wounds during surgery, trauma, and interventional care or from disease. The company's flagship products include AC5 advanced wound system and AC5 topical hemostat, which are intended for skin applications, such as management of complicated chronic wounds or acute surgical wounds. It is also involved in the development of AC5-G for gastrointestinal endoscopic procedures, and AC5-V and AC5 surgical hemostat for hemostasis inside the body. The company was founded in 2006 and is based in Framingham, Massachusetts.

GlucoTrack stock logo

GlucoTrack NASDAQ:GCTK

$5.82 +0.01 (+0.17%)
Closing price 08/8/2025 04:00 PM Eastern
Extended Trading
$5.84 +0.02 (+0.43%)
As of 08/8/2025 07:35 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

GlucoTrack, Inc., a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Rutherford, New Jersey.

United American Healthcare stock logo

United American Healthcare OTCMKTS:UAHC

$0.02 0.00 (0.00%)
As of 08/8/2025

United American Healthcare Corporation, through its subsidiaries, provides contract manufacturing services to the medical device industry. It also focuses on the production of natural rubber. The company was incorporated in 1983 and is based in Chicago, Illinois.